CA 19-9 antibody
Quick Overview for CA 19-9 antibody (ABIN94463)
Target
See all CA 19-9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Anti-Sialyl Lewis a Purified
-
Cross-Reactivity (Details)
- Other not tested, Human
-
Characteristics
- The antibody 121SLE recognizes Sialyl Lewis a-containing glycolipids (extracellular plasma membrane leaflet antigens).
-
Purification
- Purified by sequential steps of physicochemical fractionation (differential precipitation and solid-phase chromatography methods).
-
Purity
- > 95 % (by SDS-PAGE)
-
Immunogen
- Immunoprecipitate obtained after immunodiffusion of MAb 19-9 and mucins isolated from an ovarian cyst of a 0Le(a+b-) patient.
-
Isotype
- IgM
-
-
-
-
Application Notes
- Immunohistochemistry (paraffin sections): Recommended dilution: 10 μg/mL, positive control: colorectal adenocarcinoma, heat mediated antigen retrieval (sodium citrate), mAb incubation 1 hour / RT, detection DAB.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Tris buffered saline (TBS), pH 8.0, 15 mM sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Do not freeze
-
Storage
- 4 °C
-
Storage Comment
- Store at 2-8°C. Do not freeze.
-
-
-
: "Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997." in: Tumour biology, Vol. 19, Issue 5, pp. 390-420, (1998) (PubMed).
-
-
- CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
-
Alternative Name
- Sialyl Lewis a
-
Background
- CA-19.9
-
Gene ID
- 35
Target
-